Search…

Goldman Sachs: After the latest report following ASCO, we give CSPC Pharmaceutical Group (02616.HK) a "buy" rating with a target price of 9.44 HK dollars.

02/06/2026

According to the Wisdom Financial APP, Goldman Sachs released a research report stating that it has given a "buy" rating to CSPC Pharmaceutical Group Limited-B (02616.HK), with a 12-month target price of HK$9.44 based on risk-adjusted DCF.

Latest

1 m ago

Xinnowe (300765.SZ): Subsidiary SYS6043 announced research results at the 2026 American Society of Clinical Oncology Annual Meeting.

2 m ago

Tencent Cloud: In order to continuously reduce user costs, Tencent Cloud's intelligent body development platform will lower the prices of the DeepSeek-V4 series models starting at 00:00 on June 3, 2026, Beijing time, with the highest reduction reaching 97.5%.

2 m ago

Armadillo Man is considering distributing dividends starting from the next fiscal year, and may even start earlier.

2 m ago

Tencent Cloud: In order to continuously reduce user costs, Tencent Cloud's Intelligent Body Development Platform will adjust the prices of the DeepSeek-V4 series models on June 3, 2026 at 00:00 Beijing time, with the maximum discount of up to 97.5%. (Tencent Cloud)

2 m ago

Mayi Technology rose 17.92% in pre-market trading, now trading at $258.39.

+852 - 60190728

Customer Support

Commercial Services